MEI Pharma Inc. has announced a significant expansion of its operations by acquiring 929,548 Litecoin $(LTC)$ tokens, launching a $100 million institutional treasury strategy. This initiative, developed with guidance from Litecoin Creator Charlie Lee and crypto investment firm GSR, makes MEI the first U.S.-listed public company to adopt Litecoin as a primary reserve asset. The strategy aims to leverage Litecoin's scalability and reliability as a long-term store of value and operational treasury asset. MEI also plans to explore Litecoin mining activities, reflecting its commitment to innovation in capital structure and financial technology.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250805082856) on August 05, 2025, and is solely responsible for the information contained therein.
Comments